An inactivated hepatitis A virus (HAV) vaccine was tested on a group of human adult volunteers. The vaccine was administered subcutaneously, and a control group received a placebo (aluminium hydroxide). The vaccine was found to be relatively well tolerated and non-reactogenic, and levels of anti-HAV were comparable to those in other studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0264-410x(91)90238-2 | DOI Listing |
Publication Analysis
Top Keywords
inactivated hepatitis
8
hepatitis virus
8
immunogenicity trial
4
trial inactivated
4
vaccine
4
virus vaccine
4
vaccine human
4
human volunteers
4
volunteers inactivated
4
virus hav
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!